ライフサイエンスコーパス: Haemophilus influenzae

1 enes, Staphylococcus aureus, and potentially Haemophilus influenzae).

2 protective vaccine responses to tetanus and Haemophilus influenzae.

3 ccus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae.

4 ng Streptococcus pneumoniae and non-typeable Haemophilus influenzae.

5 nd in some regions, for all pathogens except Haemophilus influenzae.

6 ssue, which included known pathogens such as Haemophilus influenzae.

7 hylococcus and Gram-negative bacteria and to Haemophilus influenzae.

8 t line of defense against the human pathogen Haemophilus influenzae.

9 ococcus pneumoniae, and 54% for non-typeable Haemophilus influenzae.

10 were previously misidentified as nontypeable Haemophilus influenzae.

11 ainst efflux-negative strains of E. coli and Haemophilus influenzae.

12 s successful in creating unmarked mutants in Haemophilus influenzae.

13 crobial peptides (sap operon) in nontypeable Haemophilus influenzae.

14 luding the phylogenetically related pathogen Haemophilus influenzae.

15 eria gonorrheae, Neisseria meningitidis, and Haemophilus influenzae.

16 dA from Yersinia enterocolitica and Hia from Haemophilus influenzae.

17 abundance was associated with qPCR levels of Haemophilus influenzae.

18 (53.4%), Neisseria meningitidis (13.7%), and Haemophilus influenzae (12.3%) were the predominant isol

19 were Streptococcus pneumoniae (93 [73.8%]), Haemophilus influenzae (18 [14.3%]), and Neisseria menin

20 treptococcus pneumoniae (93 of 143, 65%) and Haemophilus influenzae (19 of 143, 13%).

21 Haemophilus influenzae (232/1670 [13.9%]) was the least

22 representing a reduced relative abundance of Haemophilus influenzae (35.3% [5.5-91.6] vs 6.7% [0.8-74

23 Pathogenic bacteria such as Haemophilus influenzae, a major cause of lower respirato

24 ibrocytes) are able to recognize nontypeable Haemophilus influenzae, a major pathogen of middle ear i

25 Haemophilus influenzae also uses an enzyme, GlpQ, to hyd

26 colonization by Streptococcus pneumoniae and Haemophilus influenzae among children has been noted in

27 Neisseria meningitidis and ceftriaxone, and Haemophilus influenzae and ceftriaxone.

28 sensitivity and specificity for identifying Haemophilus influenzae and differentiating it from H. ha

29 activity has been achieved against wild-type Haemophilus influenzae and efflux-deficient mutants of E

30 Distinguishing nontypeable Haemophilus influenzae and Haemophilus haemolyticus isol

31 ator to the respiratory pathogen nontypeable Haemophilus influenzae and identify the Haemophilus surf

32 s pneumoniae and the Gram-negative pathogens Haemophilus influenzae and Moraxella catarrhalis .

33 nization with Gram-negative bacteria such as Haemophilus influenzae and Moraxella catarrhalis was fou

34 animal models of the Gram-negative pathogens Haemophilus influenzae and Neisseria meningitidis We hyp

35 otent antibody responses against nontypeable Haemophilus influenzae and S. pneumoniae, engendering pr

36 vaccination with conjugate vaccines against Haemophilus influenzae and Streptococcus pneumoniae has

37 Haemophilus influenzae and Streptococcus pneumoniae were

38 Haemophilus influenzae and Streptococcus pneumoniae were

39 Haemophilus influenzae and Streptococcus pneumoniae were

40 piratory syncytial virus; RSV) and bacteria (Haemophilus influenzae and Streptococcus pneumoniae) in

41 ion of EVI1 itself is induced by nontypeable Haemophilus influenzae and TNF-alpha in an NF-kappaB-dep

42 In the Gram-negative bacteria Haemophilus influenzae and Vibrio cholerae, the master r

43 ccus aureus, 10 Streptococcus pneumoniae, 10 Haemophilus influenzae, and 5 Escherichia coli isolates

44 orins from Neisseriae, Shigella, Salmonella, Haemophilus influenzae, and Fusobacterium nucleatum, whi

45 Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis are th

46 antitative PCR for Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis were p

47 ovirus, bocavirus, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis were s

48 c airway bacteria (Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis) were

49 BM: Streptococcus pneumoniae (pneumococcus), Haemophilus influenzae, and Neisseria meningitidis (meni

50 of Streptococcus pneumoniae (pneumococcus), Haemophilus influenzae, and Neisseria meningitidis (meni

51 identification of Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis, the

52 as Escherichia coli, Neisseria meningitidis, Haemophilus influenzae, and Pasteurella multocida.

53 phocholine, phosphocholine-modified LPS from Haemophilus influenzae, and phosphocholine-modified prot

54 phylococci (CoNS), Streptococcus pneumoniae, Haemophilus influenzae, and Pseudomonas aeruginosa.

55 eumoniae, Staphylococcus aureus, Nontypeable Haemophilus influenzae, and Pseudomonas aeruginosa.

56 thogens: Pseudomonas aeruginosa, nontypeable Haemophilus influenzae, and Salmonella enterica serovar

57 atients, including Burkholderia cenocepacia, Haemophilus influenzae, and Staphylococcus aureus.

58 ptococcus pneumoniae, Moraxella catarrhalis, Haemophilus influenzae, and Staphylococcus aureus.

59 athogens, uropathogenic E. coli, nontypeable Haemophilus influenzae, and Staphylococcus epidermidis I

60 d Moraxella, Corynebacterium, Streptococcus, Haemophilus influenzae, and Staphylococcus.

61 Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae are

62 atory tract pathogens Moraxella catarrhalis, Haemophilus influenzae, and Streptococcus pneumoniae, bu

63 is caused mainly by Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae, in

64 itis cases caused by Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae.

65 w that EVI1 negatively regulates nontypeable Haemophilus influenzae- and TNF-alpha-induced NF-kappaB-

66 Immunoglobulin (Ig)A proteases of Haemophilus influenzae are highly specific endopeptidase

67 Neisseria meningitidis (meningococcus), and Haemophilus influenzae are major causes of this invasive

68 ococcus aureus, Streptococcus pneumoniae and Haemophilus influenzae are the major causes of conjuncti

69 Here, using non-typeable Haemophilus influenzae as a model organism, we report th

70 eudomonas aeruginosa, Staphylococcus aureus, Haemophilus influenzae, Aspergillus species, Streptococc

71 Neisseria meningitidis (meningococcus), and Haemophilus influenzae, at a sentinel hospital within th

72 5922 (0.008 to 0.03 mug/ml and 30 to 36 mm), Haemophilus influenzae ATCC 49247 (0.002 to 0.015 mug/ml

73 pneumoniae ATCC 49619 (disk and broth), and Haemophilus influenzae ATCC 49247 (disk and broth).

74 ureus ATCC 29213 (MIC range, 1 to 4 mug/ml), Haemophilus influenzae ATCC 49247 (MIC and disk diffusio

75 and ATCC 25923, Escherichia coli ATCC 25922, Haemophilus influenzae ATCC 49247, and Streptococcus pne

76 umoniae ATCC 49619, and 0.12 to 1 mug/ml for Haemophilus influenzae ATCC 49247.

77 23, Streptococcus pneumoniae ATCC 49619, and Haemophilus influenzae ATCC 4927 strains were evaluated.

78 in Southern England immunized with DTaP5/IPV/Haemophilus influenzae b (Hib-TT) vaccine at 2-3-4 month

79 tive, Moraxella catarrhalis and non-typeable Haemophilus influenzae, bacterial colonizers and pathoge

80 syncytial virus, parainfluenza viruses, and Haemophilus influenzae being the most common.

81 protection against PC-expressing nontypeable Haemophilus influenzae, but not PC-negative nontypeable

82 We present the Arg160His mutation of Haemophilus influenzae carbonic anhydrase (HICA), which

83 ve a significantly lower risk of nontypeable Haemophilus influenzae carriage in particular (relative

84 a meningitidis, Streptococcus pneumoniae, or Haemophilus influenzae cases were confirmed and N. menin

85 Pneumococcus, meningococcus, and Haemophilus influenzae cause a similar spectrum of infec

86 ella kingae (HACEK) clinical isolates and 20 Haemophilus influenzae clinical isolates.

87 Non-typeable Haemophilus influenzae contains an N(6)-adenine DNA-meth

88 Using Haemophilus influenzae Eagan strains expressing well-cha

89 Haemophilus influenzae exclusively colonizes the human n

90 son of derivatives of a laboratory strain of Haemophilus influenzae expressing either surface-associa

91 , we turned our attention to bacteria, i.e., Haemophilus influenzae, expressing cell-surface adhesins

92 Unencapsulated Haemophilus influenzae frequently causes noninvasive upp

93 marker for differentiating nontypeable (NT) Haemophilus influenzae from Haemophilus haemolyticus in

94 terial burden and a significant outgrowth of Haemophilus influenzae from the existing microbiota of s

95 on compositional lasso analysis, we selected Haemophilus influenzae (HI) and Mycoplasma penetrans (MP

96 Haemophilus influenzae (Hi) causes respiratory tract inf

97 %), Streptococcus pneumoniae ([Sp] 13%), and Haemophilus influenzae ([Hi] 2%).

98 y to inhibit catalytic activity of DapE from Haemophilus influenzae (HiDapE) and ArgE from Escherichi

99 The Haemophilus influenzae HMW1 adhesin is an N-linked glyco

100 Staphylococcus aureus in 22% of samples and Haemophilus influenzae in 14%, and both a viral and bact

101 ficiency further affected internalization of Haemophilus influenzae in bronchial epithelial cells.

102 d for TolR is of the periplasmic domain from Haemophilus influenzae in which N- and C-terminal residu

103 ry clearance of Streptococcus pneumoniae and Haemophilus influenzae in wild-type mice but not CD68.hM

104 % vs 23%-31% of AOM isolates), while that of Haemophilus influenzae increased (41%-43% vs 56%-57%) pr

105 In this study, we found that nontypeable Haemophilus influenzae induces the association of Itch w

106 he survival rate after a lethal non-typeable Haemophilus influenzae infection in wild-type mice, but

107 tudy persistent Streptococcus pneumoniae and Haemophilus influenzae infections, to show that structur

108 Novel mouse models of Chlamydia, Haemophilus influenzae, influenza, and respiratory syncy

109 Haemophilus influenzae is a Gram-negative human pathogen

110 Nontypeable Haemophilus influenzae is a major cause of localized res

111 Haemophilus influenzae is a rare cause of soft tissue in

112 Haemophilus influenzae is a significant causative agent

113 Non-typeable Haemophilus influenzae is an opportunistic pathogen of t

114 lmonary inflammation induced by non-typeable Haemophilus influenzae is significantly attenuated in IR

115 a catarrhalis, Streptococcus pneumoniae, and Haemophilus influenzae, is associated with later develop

116 configurations were predicted in nontypeable Haemophilus influenzae isolates based on the presence of

117 e operon was significantly more prevalent in Haemophilus influenzae isolates causing otitis media and

118 -resolution X-ray structure determination of Haemophilus influenzae KDO8PP bound to KDO/VO3(-) and Ba

119 d antimicrobial activity against a strain of Haemophilus influenzae lacking its major efflux pump.

120 tly from CSF specimens: Escherichia coli K1, Haemophilus influenzae, Listeria monocytogenes, Neisseri

121 ith's phylogenetic diversity (P = 0.026) and Haemophilus influenzae load (P < 0.0001).

122 we have shown that the C-terminal domain of Haemophilus influenzae LpoA (HiLpoA) has a highly conser

123 , and detailed enzymatic characterization of Haemophilus influenzae LpxH (HiLpxH).

124 ccines with/without protein D of nontypeable Haemophilus influenzae, M. catarrhalis has become a high

125 Haemophilus influenzae meningitis fluctuated over the su

126 ed as having meningococcal, pneumococcal, or Haemophilus influenzae meningitis in the period 1977-200

127 neumoniae (Spn), Neisseria meningitidis, and Haemophilus influenzae meningitis within the WHO African

128 Haemophilus influenzae (MIC(50), </= 0.008 microg/mL; MI

129 were cultured for Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staph

130 piratory pathogens Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staph

131 irways with the pathogenic bacterial strains Haemophilus influenzae, Moraxella catarrhalis, and Strep

132 y associated with bacterial coinfection with Haemophilus influenzae, Moraxella catarrhalis, or Strept

133 We assessed this association for Haemophilus influenzae, Moraxella catarrhalis, Staphyloc

134 pathogens were detected frequently, notably Haemophilus influenzae (mostly nontypeable) together wit

135 re Pseudomonas aeruginosa (n = 10 patients), Haemophilus influenzae (n = 12), Prevotella (n = 18), an

136 s simplex virus [n = 5], adenovirus [n = 5], Haemophilus influenzae [n = 5], and Streptococcus pneumo

137 lude Escherichia coli, Campylobacter jejuni, Haemophilus influenzae, Neisseria meningitidis, and Past

138 Infection with Haemophilus influenzae, Neisseria meningitidis, and Stre

139 cterial pathogens (Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis, Mycoplas

140 evarion systems in the major human pathogens Haemophilus influenzae, Neisseria meningitidis, Neisseri

141 It is closely related to nontypeable Haemophilus influenzae (NT H. influenzae).

142 ta-lactamase-producing strain of nontypeable Haemophilus influenzae (NTHi 86-028NP) and an isogenic m

143 The mucosal pathogen nontypeable Haemophilus influenzae (NTHi) adheres to the respiratory

144 Hia is a major adhesin of nontypeable Haemophilus influenzae (NTHi) and has long been investig

145 Biofilms formed by nontypeable Haemophilus influenzae (NTHI) are central to the chronic

146 Haemophilus haemolyticus and nontypeable Haemophilus influenzae (NTHi) are closely related upper

147 by Streptococcus pneumoniae and nontypeable Haemophilus influenzae (NTHi) are frequently implicated

148 Nontypeable Haemophilus influenzae (NTHI) are Gram-negative bacteria

149 istic human respiratory pathogen nontypeable Haemophilus influenzae (NTHI) are required for type IV p

150 ocator function is necessary for nontypeable Haemophilus influenzae (NTHI) behaviors that mediate dis

151 ram-negative commensal bacterium nontypeable Haemophilus influenzae (NTHI) can cause respiratory trac

152 entrations, and pneumococcal and nontypeable Haemophilus influenzae (NTHi) carriage were assessed pre

153 le interactions is important for nontypeable Haemophilus influenzae (NTHi) colonization in the airway

154 Non-typeable Haemophilus influenzae (NTHi) contains the phase-variabl

155 Nontypeable Haemophilus influenzae (NTHi) efficiently colonizes the

156 Nontypeable Haemophilus influenzae (NTHi) exclusively infects humans

157 Nontypeable Haemophilus influenzae (NTHI) forms biofilms in the midd

158 Nontypeable Haemophilus influenzae (NTHi) frequently causes noninvas

159 Studies of nontypeable Haemophilus influenzae (NTHi) have demonstrated that a n

160 reptococcus pneumoniae (Spn) and nontypeable Haemophilus influenzae (NTHi) in stringently defined oti

161 Invasive nontypeable Haemophilus influenzae (NTHi) infection among adults is

162 xed Streptococcus pneumoniae and nontypeable Haemophilus influenzae (NTHi) infections (M-OM) and thos

163 Nontypeable Haemophilus influenzae (NTHi) initiates infection by col

164 Nontypeable Haemophilus influenzae (NTHi) is a bacterium that reside

165 Nontypeable Haemophilus influenzae (NTHI) is a commensal bacterial s

166 Nontypeable Haemophilus influenzae (NTHI) is a commensal inhabitant

167 Nontypeable Haemophilus influenzae (NTHi) is a commensal microorgani

168 Nontypeable Haemophilus influenzae (NTHI) is a common commensal and

169 Nontypeable Haemophilus influenzae (NTHI) is a Gram-negative bacteri

170 Nontypeable Haemophilus influenzae (NTHi) is a Gram-negative, opport

171 Nontypeable Haemophilus influenzae (NTHI) is a leading cause of oppo

172 Nontypeable Haemophilus influenzae (NTHI) is a leading cause of otit

173 Nontypeable Haemophilus influenzae (NTHi) is a major bacterial patho

174 Non-typeable Haemophilus influenzae (NTHi) is a major cause of mucosa

175 Nontypeable Haemophilus influenzae (NTHi) is a major pathogen causin

176 Nontypeable Haemophilus influenzae (NTHi) is a pathogen known for be

177 Nasopharyngeal colonization with nontypeable Haemophilus influenzae (NTHi) is a prerequisite for deve

178 Nontypeable Haemophilus influenzae (NTHI) is a respiratory commensal

179 Nontypeable Haemophilus influenzae (NTHi) is an important bacterial

180 am-negative pathogenic bacterium nontypeable Haemophilus influenzae (NTHi) is surface exposed and a l

181 Nontypeable Haemophilus influenzae (NTHI) is the causative agent of

182 Nontypeable Haemophilus influenzae (NTHi) is the dominant bacterium

183 Nontypeable Haemophilus influenzae (NTHi) is the leading bacterial p

184 Nontypeable Haemophilus influenzae (NTHi) is the primary cause of ba

185 vaccine against nonencapsulated isolates of Haemophilus influenzae (NTHi) lies in the genetic divers

186 The type IV pilus (Tfp) of nontypeable Haemophilus influenzae (NTHI) mediates adherence, coloni

187 ere we examine the impact of the nontypeable Haemophilus influenzae (NTHI) ModA2 phasevarion on patho

188 Pneumococci and nontypeable Haemophilus influenzae (NTHi) often cocolonize children.

189 Nontypeable Haemophilus influenzae (NTHi) persists in the airways in

190 Nontypeable Haemophilus influenzae (NTHi) was selected as a model pa

191 ce lipooligosaccharides (LOS) of nontypeable Haemophilus influenzae (NTHi), a human-specific commensa

192 Nontypeable Haemophilus influenzae (NTHI), an opportunistic pathogen

193 Nontypeable Haemophilus influenzae (NTHI), an opportunistic pathogen

194 were calculated for pneumococcal, nontypable Haemophilus influenzae (NTHi), Moraxella catarrhalis, St

195 In nontypeable Haemophilus influenzae (NTHi), the oligopeptide-binding

196 l collapse of biofilms formed by nontypeable Haemophilus influenzae (NTHI), those directed against a

197 ctions with pathogens, including nontypeable Haemophilus influenzae (NTHI), yet the reasons for this

198 onization strategies employed by nontypeable Haemophilus influenzae (NTHi).

199 evelopment and colonization with nontypeable Haemophilus influenzae (NTHi).

200 l impairment of phagocytosis for nontypeable Haemophilus influenzae (NTHI).

201 ce exposed to cigarette smoke or nontypeable Haemophilus influenzae (NTHi).

202 us (PilA), two major antigens of nontypeable Haemophilus influenzae (NTHi).

203 diseases are commonly caused by nontypeable Haemophilus influenzae (NTHi).

204 asion by lung microbiota such as nontypeable Haemophilus influenzae (NTHi).

205 E) responses of ccl3(-/-)mice to nontypeable Haemophilus influenzae (NTHi).

206 by respiratory pathogens such as nontypeable Haemophilus influenzae (NTHi).

207 tly colonized with bacteria [eg, nontypeable Haemophilus influenzae (NTHi)] that cause pulmonary infl

208 crystal structure of a bacterial homologue (Haemophilus influenzae) of SLAC1 at 1.20 A resolution, a

209 or upon acute exposure to either nontypeable Haemophilus influenzae or ovalbumin.

210 Phagocytosis of fluorescently labeled Haemophilus influenzae or Streptococcus pneumoniae was a

211 onfidence interval [CI], 1.90 and 10.19) and Haemophilus influenzae (OR, 2.04; 95% CI, 1.38 and 3.02)

212 During model murine nasal colonization, Haemophilus influenzae outcompetes another member of the

213 (p = 0.001), NFkB activation by nontypeable Haemophilus influenzae (p = 0.001), TLR4 (p = 0.008) and

214 nces, most notably in potentially pathogenic Haemophilus influenzae (P = 2.7 x 10(-20)), from a preex

215 used to vaccinate children globally against Haemophilus influenzae, pneumococcus, and meningococcus.

216 A 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PCV1

217 ts of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine (PHiD

218 Haemophilus influenzae protein F (PF) is an important vi

219 The arfA hairpins from Haemophilus influenzae, Proteus mirabilis, Vibrio fische

220 m phylogenetically distant Aquifex aeolicus, Haemophilus influenzae Rd, and Synechocystis sp. were fo

221 influenzae, but not PC-negative nontypeable Haemophilus influenzae, relative to wild-type mice.

222 lls) to the respiratory pathogen nontypeable Haemophilus influenzae resulted in a marked increase in

223 us, while challenge of Trim29(-/-) mice with Haemophilus influenzae resulted in lethal lung inflammat

224 morphism in humans evades TbpA variants from Haemophilus influenzae, revealing a functional basis for

225 tococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae, S suis) and O tsutsugamushi, Ric

226 Streptococcus (GBS), Listeria monocytogenes, Haemophilus influenzae, S. aureus, Klebsiella spp. and n

227 The introduction of the Haemophilus influenzae serotype b (Hib) conjugate vaccin

228 tis in a healthy adult patient, secondary to Haemophilus influenzae serotype f infection, and we revi

229 exacerbations.Measurements and Main Results: Haemophilus influenzae, Staphylococcus aureus, Pseudomon

230 Haemophilus influenzae strains are classified as typeabl

231 and 24 months of age were cultured to detect Haemophilus influenzae, Streptococcus pneumoniae, Moraxe

232 Chinchillas were infected with nontypeable Haemophilus influenzae, Streptococcus pneumoniae, or a c

233 usters characterized by enrichment of either Haemophilus influenzae, Streptococcus, Corynebacterium,

234 e show that glucocorticoids and non-typeable Haemophilus influenzae synergistically upregulate IRAK-M

235 abs positive for Streptococcus pneumoniae or Haemophilus influenzae than were males (OR 9.09; 95% CI

236 Signaling mechanisms used by Haemophilus influenzae to adapt to conditions it encount

237 Upon exposure of serum-sensitive Haemophilus influenzae to human serum, Ecb protected the

238 of a collection of compound fragments using Haemophilus influenzae TrmD identified inhibitory, fused

239 n the first detection of 2 cases of invasive Haemophilus influenzae type a (Hia) disease in Italy.

240 e than 95% of all preterm groups, except for Haemophilus influenzae type b (88.1%).

241 t diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae type b (DTaP-IPV-Hib) administere

242 tetanus, pertussis, hepatitis B, polio, and Haemophilus influenzae type b (DTaP-IPV-Hib) and pneumoc

243 s-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b (DTaP-IPV-Hib) vaccine sin

244 A conjugate vaccine containing Haemophilus influenzae type b (Hib) and group C meningoc

245 treptococcus pneumoniae (S. pneumoniae), and Haemophilus influenzae type b (Hib) are three most commo

246 attributable to Streptococcus pneumoniae and Haemophilus influenzae type b (Hib) between 2000 and 201

247 ed (DTaP), inactivated poliovirus (IPV), and Haemophilus influenzae type b (Hib) conjugate vaccine (D

248 e United States in the early 1990s, when the Haemophilus influenzae type b (Hib) conjugate vaccine fo

249 Haemophilus influenzae type b (Hib) conjugate vaccine, d

250 The widespread use of Haemophilus influenzae type b (Hib) conjugate vaccines h

251 The incidence of invasive Haemophilus influenzae type b (Hib) disease has signific

252 ng hospital in Malawi during introduction of Haemophilus influenzae type b (Hib) vaccination and the

253 Haemophilus influenzae type b (Hib) vaccine and the 13-v

254 rst country in Africa to introduce conjugate Haemophilus influenzae type b (Hib) vaccine, which, as i

255 Streptococcus pneumoniae polysaccharide and Haemophilus influenzae type b (Hib) vaccines in ITP pati

256 Protection against Haemophilus influenzae type b (Hib), a rapidly invading

257 ribitol (PRP) polysaccharides extracted from Haemophilus influenzae type b (Hib), and the correspondi

258 duction of vaccines against pneumococcus and Haemophilus influenzae type b (the most important causes

259 om RSV, 12,600 from influenza, and 7200 from Haemophilus influenzae type b and 24,700 diarrheal death

260 become the predominant invasive pathogen as Haemophilus influenzae type b and pneumococcal vaccine u

261 ca, the widespread use of vaccines targeting Haemophilus influenzae type b and Streptococcus pneumoni

262 and of occult bacteremia since the advent of Haemophilus influenzae type b and Streptococcus pneumoni

263 cal serotypes varied between 83.0% and 100%, Haemophilus influenzae type b between 34.7% and 46.2% (4

264 -tetanus-acellular pertussis-inactived polio-Haemophilus influenzae type b combined vaccine (DTaP-IPV

265 C, W, Y polysaccharide vaccine (PsACWY); or Haemophilus influenzae type b conjugate vaccine (Hib-TT)

266 Literature on hepatitis B, rotavirus, Haemophilus influenzae type b conjugate, and pneumococca

267 clinical significance and characteristics of Haemophilus influenzae type b genogroup strains isolated

268 Five genetic islands (HiGI) found in Haemophilus influenzae type b strain Eagan were used as

269 a, tetanus, pertussis, measles, rubella, and Haemophilus influenzae type b vaccine antigens were comp

270 vaccine in 2, meningococcal serogroup A and Haemophilus influenzae type b vaccine each in 1 patient)

271 s-acellular pertussis-inactivated poliovirus/Haemophilus influenzae type b vaccine; age 6/10/ 14 week

272 r pertussis, inactivated polio, hepatitis B, Haemophilus influenzae type b vaccines); (2) 4CMenB at 2

273 ng countries in 2015, using pneumococcal and Haemophilus influenzae type b vaccines.

274 , and whole-cell pertussis; hepatitis B; and Haemophilus influenzae type b) and pneumococcal vaccine.

275 , tetanus, pertussis, hepatitis B virus, and Haemophilus influenzae type b), yellow fever, measles, a

276 ent vaccine (diphtheria, tetanus, pertussis, Haemophilus influenzae type b, and hepatitis B) at 6, 10

277 include pneumococcus, group B Streptococcus, Haemophilus influenzae type b, and meningococcus vaccine

278 against some types of bacterial meningitis (Haemophilus influenzae type b, Neisseria meningitidis gr

279 to characterise disease syndromes caused by Haemophilus influenzae type b, pneumococcus, rotavirus,

280 diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b, Streptococcus pneumoniae,

281 cine priming, before a booster of a combined Haemophilus influenzae type b-MenC conjugate vaccine and

282 r the primary series and booster, except for Haemophilus influenzae type b.

283 from ALRI, after pneumococcal pneumonia and Haemophilus influenzae type b.

284 pathogens were Streptococcus pneumoniae and Haemophilus influenzae (type B and non-type B).

285 The bacterium Haemophilus influenzae typically colonizes the human upp

286 The pathogens Vibrio cholerae and Haemophilus influenzae use tripartite ATP-independent pe

287 zed with the P6 lipoprotein from nontypeable Haemophilus influenzae, using 17-HDHA and aspirin-trigge

288 ribution of solvent to ligand binding in the Haemophilus influenzae virulence protein SiaP.

289 the sialic acid-specific SBP, SiaP, from the Haemophilus influenzae virulence-related SiaPQM TRAP tra

290 ctivity against an efflux-negative strain of Haemophilus influenzae was 4- to 8-fold higher, the comb

291 Neisseria meningitidis (meningococcus), and Haemophilus influenzae was performed by microbiological

292 Haemophilus influenzae was present in more adenoids from

293 Haemophilus influenzae was unencapsulated in all 10 epis

294 Working with the bacterium Haemophilus influenzae, we found that MolBC-A functions

295 caused by either Streptococcus pneumoniae or Haemophilus influenzae were compared for pathogen-specif

296 phtericum and Corynebacterium propinquum and Haemophilus influenzae were significantly more abundant

297 the sialic acid TRAP transporter SiaPQM from Haemophilus influenzae, where the membrane proteins are

298 een H. parainfluenzae and its close relative Haemophilus influenzae, which is also commonly carried w

299 on X-ray crystal structures of the DapE from Haemophilus influenzae with one and two zinc ions bound

300 sis initiates with Staphylococcus aureus and Haemophilus influenzae, with later emergence of Pseudomo